This document summarizes important drugs used in gastrointestinal diseases and disorders. It describes the mechanism of action, clinical applications, pharmacokinetics, and toxicities of drugs that act as proton pump inhibitors, H2 receptor blockers, sucralfate, antacids, prokinetic agents, drugs for irritable bowel syndrome, antiemetics, laxatives, and antidiarrheal drugs. Key classes of drugs discussed include proton pump inhibitors like omeprazole, H2 receptor blockers, metoclopramide, alosetron, ondansetron, lubiprostone, loperamide, and bismuth subsalicylate.
This document summarizes important drugs used in gastrointestinal diseases and disorders. It describes the mechanism of action, clinical applications, pharmacokinetics, and toxicities of drugs that act as proton pump inhibitors, H2 receptor blockers, sucralfate, antacids, prokinetic agents, drugs for irritable bowel syndrome, antiemetics, laxatives, and antidiarrheal drugs. Key classes of drugs discussed include proton pump inhibitors like omeprazole, H2 receptor blockers, metoclopramide, alosetron, ondansetron, lubiprostone, loperamide, and bismuth subsalicylate.
This document summarizes important drugs used in gastrointestinal diseases and disorders. It describes the mechanism of action, clinical applications, pharmacokinetics, and toxicities of drugs that act as proton pump inhibitors, H2 receptor blockers, sucralfate, antacids, prokinetic agents, drugs for irritable bowel syndrome, antiemetics, laxatives, and antidiarrheal drugs. Key classes of drugs discussed include proton pump inhibitors like omeprazole, H2 receptor blockers, metoclopramide, alosetron, ondansetron, lubiprostone, loperamide, and bismuth subsalicylate.
Subclass Mechanism of Action Clinical Applications Pharmacokinetics Toxicities, Drug
Interactions Drugs used in acid-peptic diseases Proton pump Irreversible blockade of H+/ K+ ATPase Peptic ulcer, GERD, Half-lives much Low toxicity; reduction of inhibitors (eg, in active gastric parietal; long-lasting erosive gastritis shorter than duration stomach acid may reduce omeprazole) reduction of stimulated and nocturnal of action absorption of some drugs acid secretion and increase that of others
Other proton pump inhibitors: Esomeprazole, lansoprazole, pantoprazole, rabeprazole
H2-receptor blockers: Cimetidine, famotidine, nizatidine, ranitidine reduce nocturnal acid but less effective against stimulated secretion; very safe, available over the counter (OTC). Cimetidine, but not other H 2 blockers, is a weak anti-androgenic agent and a potent CYP enzyme inhibitor Sucralfate: Polymerizes at site of tissue damage and protects against further damage; very insoluble with no systemic effects; must be given 4 times daily Antacids: Popular OTC medication for symptomatic relief of heartburn; not as useful as proton pump inhibitors and H 2 blockers in peptic diseases Prokinetic agents Metoclopramide D2 receptor blocker; increases gastric Gastric paresis (eg, Oral and parenteral Parkinsonian symptoms emptying and intestinal motility in diabetes); formulations due to block of CNS D2 antiemetic receptors
Domperidone: Like metoclopramide but less CNS effect; not available in United States Cholinomimetics: Neostigmine used for colonic pseudo-obstruction in hospitalized patients Macrolides: Erythromycin useful in diabetic gastroparesis but tolerance develops Drugs for irritable bowel syndrome (IBS) Alosetron 5-HT3 antagonist of high potency and Severe diarrhea- Oral Rare but serious duration of binding; reduces smooth predominant IBS in constipation; ischemic muscle activity in gastrointestinal (GI) women colitis; bowel infarction tract
Anticholinergics: Nonselective action on GI activity; associated with typical antimuscarinic toxicity Chloride channel activator: Lubiprostone is useful in constipation-predominant IBS in women Antiemetics 5-HT3 antagonists (eg, 5-HT3 block in GI and CNS Prevention of Oral and parenteral May slow colonic transit ondansetron) chemotherapy- formulations induced and postoperative nausea and vomiting Other 5-HT3 antagonist antiemetics: Dolasetron, granisetron, palonosetron; Corticosteroids: Mechanism not known but useful in antiemetic IV cocktails; Antimuscarinics (eg, scopolamine): Effective in emesis due to motion sickness; not other types; Phenothiazines: Act primary through block of D2 and muscarinic receptors; Cannabinoids: Dronabinol is available for use in chemotherapy-induced nausea and vomiting, but is associated with CNS marijuana effects Aprepitant: A neurokinin 1 (NK1) antagonist available for use in chemotherapy-induced nausea and vomiting; associated with fatigue, dizziness, diarrhea, and CYP interactions Laxatives Magnesium Osmotic agents increase water Simple Oral Magnesium may be hydroxide, other content of stool constipations; absorbed and cause nonabsorbable salts bowel prep for toxicity in renal and sugars endoscopy impairment (especially PEG solutions) Bulk-forming: Methylcellulose, psyllium, etc; increase volume, stimulate evacuation Stool surfactants: Docusate, mineral oil; lubricate stool, ease passage Stimulants: Senna, cascara; stimulate activity; may cause cramping Chloride channel activator: Lubiprostone, prostanoic acid derivative, stimulates chloride secretion into intestine, increasing fluid content Opioid receptor antagonists: Alvimopan, methylnaltrexone, block intestinal -opioid receptors but do not enter CNS, so analgesia is maintained 5-HT4 agonists: Tegaserod; activates enteric 5-HT4 receptors and increases intestinal motility Antidiarrheal drugs Loperamide Activates -opioid receptors in enteric Nonspecific, Oral Mild cramping but little or nervous system and slows motility noninfectious no CNS toxicity with negligible CNS effects diarrhea Diphenoxylate: Similar to loperamide, but high doses can cause CNS opioid effects and toxicity Colloidal bismuth compounds: Subsalicylate and citrate salts available as over-the-counter products; have some value in travelers' diarrhea due to absorption of toxins Kaolin + pectin: Adsorbent compounds available OTC